1.
Product Overview
2.
Research Methodology
3.
Impact of COVID-19 on Global Liver Cancer Therapeutics
Market
4.
Voice of Customer
5. Executive Summary
6. Global Liver Cancer
Therapeutics Market Outlook
6.1.
Market Size & Forecast
6.1.1.
By Value
6.2.
Market Share & Forecast
6.2.1. By Cancer Type
(Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatoblastoma, Angiosarcoma,
Liver Metastasis)
6.2.2. By Therapy (Targeted
Therapy, Chemotherapy and Radiation Therapy, Immunotherapy, Others)
6.2.3. By Equipment (Computed
Radiography, Sonography, MRI, Others)
6.2.4. By Age (0-18, 18-35,
35-50, 50+)
6.2.5. By Factors (Cirrhosis,
Nonalcoholic Fatty Liver Disease, Excessive Alcohol Consumption, Others)
6.2.6. By Route of
Administration (Oral, Intravenous, Others)
6.2.7. By Distribution
Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
6.2.8. By Company (2019)
6.2.9. By Region
6.3. Market Attractiveness Index
7. Asia-Pacific Liver
Cancer Therapeutics Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1. By Cancer Type
7.2.2. By Therapy
7.2.3. By Equipment
7.2.4. By Age
7.2.5. By Factors
7.2.6. By Route of
Administration
7.2.7.
By Country
7.3.
Asia-Pacific: Country Analysis
7.3.1.
China Liver Cancer Therapeutics Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Cancer Type
7.3.1.2.2.
By Therapy
7.3.1.2.3.
By Equipment
7.3.1.2.4.
By Age
7.3.1.2.5.
By Factors
7.3.1.2.6.
By Route of Administration
7.3.2.
India Liver Cancer Therapeutics Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Cancer Type
7.3.2.2.2.
By Therapy
7.3.2.2.3.
By Equipment
7.3.2.2.4.
By Age
7.3.2.2.5.
By Factors
7.3.2.2.6.
By Route of Administration
7.3.3.
Japan Liver Cancer Therapeutics Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Cancer Type
7.3.3.2.2.
By Therapy
7.3.3.2.3.
By Equipment
7.3.3.2.4.
By Age
7.3.3.2.5.
By Factors
7.3.3.2.6.
By Route of Administration
7.3.4.
South Korea Liver Cancer Therapeutics Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Cancer Type
7.3.4.2.2.
By Therapy
7.3.4.2.3.
By Equipment
7.3.4.2.4.
By Age
7.3.4.2.5.
By Factors
7.3.4.2.6.
By Route of Administration
7.3.5.
Australia Liver Cancer Therapeutics Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Cancer Type
7.3.5.2.2.
By Therapy
7.3.5.2.3.
By Equipment
7.3.5.2.4.
By Age
7.3.5.2.5.
By Factors
7.3.5.2.6.
By Route of Administration
8. Europe Liver Cancer
Therapeutics Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1. By Cancer Type
8.2.2. By Therapy
8.2.3. By Equipment
8.2.4. By Age
8.2.5. By Factors
8.2.6. By Route of
Administration
8.2.7.
By Country
8.3.
Europe: Country Analysis
8.3.1.
France Liver Cancer Therapeutics Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Cancer Type
8.3.1.2.2.
By Therapy
8.3.1.2.3.
By Equipment
8.3.1.2.4.
By Age
8.3.1.2.5.
By Factors
8.3.1.2.6.
By Route of Administration
8.3.2.
Germany Liver Cancer Therapeutics Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Cancer Type
8.3.2.2.2.
By Therapy
8.3.2.2.3.
By Equipment
8.3.2.2.4.
By Age
8.3.2.2.5.
By Factors
8.3.2.2.6.
By Route of Administration
8.3.3.
United Kingdom Liver Cancer Therapeutics
Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Cancer Type
8.3.3.2.2.
By Therapy
8.3.3.2.3.
By Equipment
8.3.3.2.4.
By Age
8.3.3.2.5.
By Factors
8.3.3.2.6.
By Route of Administration
8.3.4.
Italy Liver Cancer Therapeutics Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Cancer Type
8.3.4.2.2.
By Therapy
8.3.4.2.3.
By Equipment
8.3.4.2.4.
By Age
8.3.4.2.5.
By Factors
8.3.4.2.6.
By Route of Administration
8.3.5.
Spain Liver Cancer Therapeutics Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Cancer Type
8.3.5.2.2.
By Therapy
8.3.5.2.3.
By Equipment
8.3.5.2.4.
By Age
8.3.5.2.5.
By Factors
8.3.5.2.6.
By Route of Administration
9. North America Liver
Cancer Therapeutics Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1. By Cancer Type
9.2.2. By Therapy
9.2.3. By Equipment
9.2.4. By Age
9.2.5. By Factors
9.2.6. By Route of
Administration
9.2.7.
By Country
9.3.
North America: Country Analysis
9.3.1.
United States Liver Cancer Therapeutics
Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Cancer Type
9.3.1.2.2.
By Therapy
9.3.1.2.3.
By Equipment
9.3.1.2.4.
By Age
9.3.1.2.5.
By Factors
9.3.1.2.6.
By Route of Administration
9.3.2.
Mexico Liver Cancer Therapeutics Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Cancer Type
9.3.2.2.2.
By Therapy
9.3.2.2.3.
By Equipment
9.3.2.2.4.
By Age
9.3.2.2.5.
By Factors
9.3.2.2.6.
By Route of Administration
9.3.3.
Canada Liver Cancer Therapeutics Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Cancer Type
9.3.3.2.2.
By Therapy
9.3.3.2.3.
By Equipment
9.3.3.2.4.
By Age
9.3.3.2.5.
By Factors
9.3.3.2.6.
By Route of Administration
10. South America Liver
Cancer Therapeutics Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share & Forecast
10.2.1. By Cancer Type
10.2.2. By Therapy
10.2.3. By Equipment
10.2.4. By Age
10.2.5. By Factors
10.2.6. By Route of Administration
10.2.7.
By Country
10.3.
South America: Country Analysis
10.3.1.
Brazil Liver Cancer Therapeutics Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Cancer Type
10.3.1.2.2.
By Therapy
10.3.1.2.3.
By Equipment
10.3.1.2.4.
By Age
10.3.1.2.5.
By Factors
10.3.1.2.6.
By Route of Administration
10.3.2.
Argentina Liver Cancer Therapeutics Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Cancer Type
10.3.2.2.2.
By Therapy
10.3.2.2.3.
By Equipment
10.3.2.2.4.
By Age
10.3.2.2.5.
By Factors
10.3.2.2.6.
By Route of Administration
10.3.3.
Colombia Liver Cancer Therapeutics Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Cancer Type
10.3.3.2.2.
By Therapy
10.3.3.2.3.
By Equipment
10.3.3.2.4.
By Age
10.3.3.2.5.
By Factors
10.3.3.2.6.
By Route of Administration
11. Middle East and
Africa Liver Cancer Therapeutics Market Outlook
11.1.
Market Size & Forecast
11.1.1.
By Value
11.2.
Market Share & Forecast
11.2.1. By Cancer Type
11.2.2. By Therapy
11.2.3. By Equipment
11.2.4. By Age
11.2.5. By Factors
11.2.6. By Route of
Administration
11.2.7.
By Country
11.3.
MEA: Country Analysis
11.3.1.
South Africa Liver Cancer Therapeutics
Market Outlook
11.3.1.1.
Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2.
Market Share & Forecast
11.3.1.2.1.
By Cancer Type
11.3.1.2.2.
By Therapy
11.3.1.2.3.
By Equipment
11.3.1.2.4.
By Age
11.3.1.2.5.
By Factors
11.3.1.2.6.
By Route of Administration
11.3.2.
Saudi Arabia Liver Cancer Therapeutics
Market Outlook
11.3.2.1.
Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2.
Market Share & Forecast
11.3.2.2.1.
By Cancer Type
11.3.2.2.2.
By Therapy
11.3.2.2.3.
By Equipment
11.3.2.2.4.
By Age
11.3.2.2.5.
By Factors
11.3.2.2.6.
By Route of Administration
11.3.3.
UAE Liver Cancer Therapeutics Market Outlook
11.3.3.1.
Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2.
Market Share & Forecast
11.3.3.2.1.
By Cancer Type
11.3.3.2.2.
By Therapy
11.3.3.2.3.
By Equipment
11.3.3.2.4.
By Age
11.3.3.2.5.
By Factors
11.3.3.2.6.
By Route of Administration
12.
Market Dynamics
12.1.
Drivers
12.2.
Challenges
13.
Market Trends & Developments
14.
Competitive Landscape
14.1.
Competition Outlook
14.2.
Players Profiled (Leading Companies)
14.2.1.
AbbVie Inc.
14.2.2.
Alnylam Pharmaceuticals Inc.
14.2.3.
Amgen Inc.
14.2.4.
AstraZeneca
14.2.5.
Bayer AG
14.2.6.
Bristol-Myers Squibb Company
14.2.7.